Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level-The "Normotensive Non-dipper" paradox

Chronobiology International

Volumn 30, Issue 1-2, 2013, Pages 87-98

  Hermida, Ramón C ^a   Ayala, Diana E ^a   Mojón, Artemio ^a   Fernández, José R ^a  

^a UNIVERSITY OF VIGO   (Spain)

Author keywords

Ambulatory blood pressure monitoring; Cardiovascular risk; Dipper; Hypertension; Non dipper; Normotension; Sleep time blood pressure

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ACTIMETRY; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CIRCADIAN RHYTHM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; FOLLOW UP; HEART MUSCLE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; RISK FACTOR; SLEEP; STATISTICAL MODEL; TIME;

ACTIGRAPHY; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MODELS, STATISTICAL; MYOCARDIUM; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SLEEP; TIME FACTORS;

EID: 84874170950     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.3109/07420528.2012.701127     Document Type: Article

References (72)

1. Astrup AS, Nielsen FS, Rossing P, Ali S, Kastrup J, Smidt UM, Parving HH. (2007). Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study. J. Hypertens. 25:2479-2485. (Pubitemid 350060387)
2. Ayala DE, Hermida RC, Mojón A, Fernández Jr. (2013). Cardiovascular risk of resistant hypertension: Dependence on treatment-time regimen of blood pressure-lowering medications. Chronobiol. Int. 30:340-352.
3. Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. (2007). Predictors of all-cause mortality in clinical ambulatory monitoring. Unique aspects of blood pressure during sleep. Hypertension 49:1235-1241. (Pubitemid 46809363)
4. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund- Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen CH, Lind L, Ibsen H, Imai Y, Wang J, Sandoya E, O'Brien E, Staessen JA. (2007). Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 370:1219-1229. (Pubitemid 47503300)
5. Bouhanick B, Bongard V, Amar J, Bousquel S, Chamontin B. (2008). Prognostic value of nocturnal blood pressure and reverse-dipping status on the occurrence of cardiovascular events in hypertensive diabetic patients. Diabetes Metab. 34:560-567.
6. Brotman DJ, Davidson MB, Boumitri M, Vidt DG. (2008). Impaired diurnal blood pressure variation and all-cause mortality. Am. J. Hypertens. 21:92-97.
7. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, JonesDW,Materson BJ, Oparil S,Wright JT, Rocella EJ, the National High Blood Pressure Education Coordinating Committee. (2003). The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 289:2560-2571.
8. Crespo C, Aboy M, Fernández JR, Mojón A. (2012). Automatic identification of activity-rest periods based on actigraphy. Med. Biol. Eng. Comput. 50:329-340.
9. Crespo C, Fernández JR, Aboy M, Mojón A. (2013). Clinical application of a novel automatic algorithm for actigraphy-based activity and rest period identification to accurately determine awake and asleep ambulatory blood pressure parameters and cardiovascular risk. Chronobiol. Int. 30:43-54.
10. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E. (2005). Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study. Hypertension 46:156-161. (Pubitemid 40946507)
11. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. (2008). Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 51:55-61. (Pubitemid 350307104)
12. Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, KikuyaM, Björklund- Bodegard K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Ibsen H, O'Brien E, Wang J, Staessen JA. (2010). Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J. Hypertens. 28:2036-2045.
13. Gallerani M, Portaluppi F, Grandi E, Manfredini R. (1997). Circadian rhythmicity in the occurrence of spontaneous acute dissection and rupture of thoracic aorta. J. Thorac. Cardiovasc. Surg. 113:603-604. (Pubitemid 27149145)
14. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Frauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. (2005). Diagnosis and management of the metabolic syndrome. An American heart Association/national heart, lung, and blood institute scientific statement. Circulation 112:2735-2752. (Pubitemid 41532612)
15. Guidelines Committee. (2003). 2003 European Society of Hypertension- European Society of Cardiology guidelines for the management of arterial hypertension. J. Hypertens. 21:1011-1053.
16. Hermida RC. (1999). Time-qualified reference values for 24 h ambulatory blood pressure monitoring. Blood Press. Monit. 4:137-147.
17. Hermida RC. (2007). Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study. Chronobiol. Int. 24:749-775. (Pubitemid 47263103)
18. Hermida RC, Ayala DE. (2003). Sampling requirements for ambulatory blood pressure monitoring in the diagnosis of hypertension in pregnancy. Hypertension 42:619-624. (Pubitemid 37237363)
19. Hermida RC, Ayala DE. (2009). Chronotherapy with the angiotensinconverting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. Hypertension 54:40-46.
20. Hermida RC, Fernández Jr. (1996). Computation of time-specified tolerance intervals for ambulatorily monitored blood pressure. Biomed. Instrum. Technol. 30:257-266. (Pubitemid 26161490)
21. Hermida RC, Smolensky MH. (2004). Chronotherapy of hypertension. Curr. Opin. Nephrol. Hypertens. 13:501-505. (Pubitemid 39150075)
22. Hermida RC, Mojón A, Fernández JR, Ayala DE. (1996). Computerbased medical system for the computation of blood pressure excess in the diagnosis of hypertension. Biomed. Instrum. Technol. 30:267-283. (Pubitemid 26161491)
23. Hermida RC, Fernández JR, Mojón A, Ayala DE. (2000). Reproducibility of the hyperbaric index as a measure of blood pressure excess. Hypertension 35:118-125. (Pubitemid 30054247)
24. Hermida RC, Ayala DE, Fernández JR, Mojón A, Alonso I, Calvo C. (2002a). Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysis. Chronobiol. Int. 19:461-481. (Pubitemid 34478039)
25. Hermida RC, Calvo C, Ayala DE, Fernández JR, Ruilope LM, López JE. (2002b). Evaluation of the extent and duration of the "ABPM effect" in hypertensive patients. J. Am. Coll. Cardiol. 40:710-717. (Pubitemid 34925618)
26. Hermida RC, Calvo C, Ayala DE, Mojón A, López JE. (2002c). Relationship between physical activity and blood pressure in dipper and nondipper hypertensive patients. J. Hypertens. 20:1097-1104. (Pubitemid 34913627)
27. Hermida RC, Mojón A, Fernández JR, Alonso I, Ayala DE. (2002d). The tolerance-hyperbaric test: A chronobiologic approach for improved diagnosis of hypertension. Chronobiol. Int. 19:1183-1211. (Pubitemid 36008225)
28. Hermida RC, Calvo C, Ayala DE, López JE, Fernández JR, Mojón A, Domínguez MJ, Covelo M. (2003). Seasonal variation of fibrinogen in dipper and nondipper hypertensive patients. Circulation 108:1101-1106. (Pubitemid 37071521)
29. Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, Fontao MJ, López JE. (2004). Administration-time- dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects. Chronobiol. Int. 21:277-296. (Pubitemid 39014625)
30. Hermida RC, Ayala DE, Calvo C. (2005). Administration time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure. Curr. Opin. Nephrol. Hypertens. 14:453-459. (Pubitemid 41152708)
31. Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. (2007). Chronotherapy of hypertension: administration-time dependent effects of treatment on the circadian pattern of blood pressure. Adv. Drug Deliv. Rev. 59:923-939. (Pubitemid 47531897)
32. Hermida RC, Ayala DE, Fernández JR, Calvo C. (2007b). Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 50:715-722. (Pubitemid 47442736)
33. Hermida RC, Ayala DE. Fernandez JR, Mojón A, Calvo C. (2007c). Influence of measurement duration and frequency on ambulatory blood pressure monitoring. Rev. Esp. Cardiol. 60:131-138. (Pubitemid 46566967)
34. Hermida RC, Ayala DE, Chayán L, Mojón A, Fernández Jr. (2009). Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol. Int. 26:61-79.
35. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2010). Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol. Int. 27:1629-1651.
36. Hermida RC, Ayala DE, Fernández JR, Portaluppi F, Fabbian F, Smolensky MH. (2011a). Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. Am. J. Hypertens. 24:383-391.
37. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2011b). Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J. Am. Coll. Cardiol. 58:1165-1173.
38. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2011c). Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care 34:1270-1276.
39. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2011d). Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J. Am. Soc. Nephrol. 22:2313-2321.
40. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2012a). Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes. Am. J. Hypertens. 25:325-334.
41. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2012b). Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension. Am. J. Hypertens. 25:297-305.
42. Hermida RC, Ayala DE, Fernández JR, Mojón A. (2013a). Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol. Int. 30:68-86.
43. Hermida RC, Ayala DE, Fernández JR, Mojón A, Smolensky MH, Fabbian F, Portaluppi F. (2013b). Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiol. Int. 30:159-175.
44. Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández Jr. (2013). Ambulatory blood pressure monitoring: importance of sampling rate and duration - 48 versus 24 hours - on the accurate assessment of cardiovascular risk. Chronobiol. Int. 30:55-67.
45. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2013d). Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications. Chronobiol. Int. 30:315-327.
46. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2013e). Role of timeof-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk. Chronobiol. Int. 30:328-339.
47. Hoshide S, Kario K, Hoshide Y, Umeda Y, Hashimoto T, Kunii O, Ojima T, Shimada K. (2003). Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am. J. Hypertens. 16:434-438. (Pubitemid 36667796)
48. Ingelsson E, Bjorklund-Bodegard K, Lind L, Arnlov J, Sundstrom J. (2006). Diurnal blood pressure pattern and risk of congestive heart failure. JAMA 295:2859-2866. (Pubitemid 43974183)
49. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. (2005). Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality. The Ohasama Study. Hypertension 45:240-245. (Pubitemid 40179967)
50. Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, for the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI). (2009). A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150:604-612.
51. Li L, Soonthornpun S, Chongsuvivatwong V. (2008). Association between circadian rhythm of blood pressure and glucose tolerance status in normotensive, non-diabetic subjects. Diabetes Res. Clin. Pract. 82:359-363.
52. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker HAJ, Zanchetti A. (2007). 2007 guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25:1105-1187. (Pubitemid 46924065)
53. Manfredini R, Portaluppi F, Grandi E, Fersini C, Gallerani M. (1996). Out-of-hospital sudden death referring to an emergency department. J. Clin. Epidemiol. 49:865-868. (Pubitemid 26283397)
54. Manfredini R, Boari B, Bressan S, Gallerani M, Salmi R, Portaluppi F, Mehta RH. (2004). Influence of circadian rhythm on mortality after myocardial infarction: Data from a prospective cohort of emergency calls. Am. J. Emerg. Med. 22:555-559. (Pubitemid 40143236)
55. Myredal A, Friberg P, Johansson M. (2010). Elevated myocardial repolarization lability and arterial baroreflex dysfunction in healthy individuals with nondipping blood pressure pattern. Am. J. Hypertens. 23:255-259.
56. Nakano S, Fukuda M, Hotta F, Ito T, Ishii T, Kitazawa M, Nishizawa M, Kigoshi T, Uchida K. (1998). Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal events in NIDDM subjects. Diabetes 47:1501-1506. (Pubitemid 28396956)
57. National Institute for Health and Clinical Excellence. (2011). Hypertension: The clinical management of primary hypertension in adults. Clinical guideline: Methods, evidence and recommendations. http://guidance.nice. org.uk/CG/Wave2/14. Last accessed April 13, 2012.
58. National Kidney Foundation. (2002). K/DOQI clinical practice guidelines on chronic kidney disease: Evaluation, classification and stratification. Am. J. Kidney Dis. 39(2 Suppl 1):S1-S266.
59. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y. (2002). Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: The Ohasama study. J. Hypertens. 20:2183-2189. (Pubitemid 35388236)
60. Portaluppi F, Hermida RC. (2007). Circadian rhythms in cardiac arrhythmias and opportunities for their chronotherapy. Adv. Drug Deliv. Rev. 59:940-951. (Pubitemid 47534217)
61. Portaluppi F, Smolensky MH. (2010). Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study. Chronobiol. Int. 27:1652-1667.
62. Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol. Int. 27:1911-1929.
63. Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. (2012). Circadian rhythms and cardiovascular health. Sleep Med. Rev. 16:151-166.
64. Rodrigues TC, Canani LH, Viatroski RS, Hoffman LH, Esteves JF, Gross JL. (2010). Masked hypertension, nocturnal blood pressure and retinopathy in normotensive patients with type 1 diabetes. Diabetes Res. Clin. Pract. 87:240-245.
65. Shimada K, Kario K. (1997). Altered circadian rhythm of blood pressure and cerebrovascular damage. Blood Press. Monit. 2:333-338. (Pubitemid 28035137)
66. Smith DH, Neutel JM, Lacourciere Y, Kempthorne-Rawson J. (2003). Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebocontrolled trials with respect to ABPM measurements. J. Hypertens. 21:1291-1298.
67. Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. (2010). Administration-time-dependent effect of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press. Monit. 15:173-180.
68. Smolensky MH, Siegel RA, Haus E, Hermida R, Portaluppi F. (2012). Biological rhythms, drug delivery, and chronotherapeutics. In Siepmann J, Siegel RA, Rathbone MJ (Eds.). Fundamentals and applications of controlled release drug delivery. Heidelberg, Germany: Springer Verlag, pp. 359-443.
69. Soylu A, Yazici M, Duzenli MA, Tokac M, Ozdemir K, Gok H. (2009). Relation between abnormalities in circadian blood pressure rhythm and target organ damage in normotensives. Circ. J. 73:899-904.
70. Sturrock NDC, George E, Pound N, Stevenson J, Peck GM, Sowter H. (2000). Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabet. Med. 17:360-364. (Pubitemid 30353800)
71. TimioM, Venanzi S, Lolli S, Lippi G, Verdura C, Monarca C, Guerrini E. (1995). "Non-dipper" hypertensive patients and progressive renal insufficiency: A 3-year longitudinal study. Clin. Nephrol. 43:382-387.
72. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistell M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. (1994). Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 24:793-801. (Pubitemid 24363980)